Phase 1 Relapsed Large B-cell Lymphoma Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
TICAROS Co., Ltd.98 enrolled1 locationNCT07473167
Recruiting
Phase 1Phase 2
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
Curocell Inc.91 enrolled1 locationNCT04836507